Yi Wang

机构：Shanxi Medical University, Nankai University, Shanxi Provincial People’s Hospital · ORCID：0000-0002-1043-7156

发表论文 40 篇 · 总被引 964 次 · h-index 14

代表论文

• CXCR6 is required for antitumor efficacy of intratumoral CD8 + T cell (2021 · Journal for ImmunoTherapy of Cancer · 被引 108)
• Target-Dependent Expression of IL12 by synNotch Receptor-Engineered NK92 Cells Increases the Antitumor Activities of CAR-T Cells (2019 · Frontiers in Oncology · 被引 49)
• Multicore-shell MnO2@Ppy@N-doped porous carbon nanofiber ternary composites as electrode materials for high-performance supercapacitors (2023 · Journal of Colloid and Interface Science · 被引 46)
• Core-shell Ppy@N-doped porous carbon nanofiber-based electrodes for high-property supercapacitors (2023 · Colloids and Surfaces A Physicochemical and Engineering Aspects · 被引 31)
• Synergistic killing effects of PD-L1-CAR T cells and colorectal cancer stem cell-dendritic cell vaccine-sensitized T cells in ALDH1-positive colorectal cancer stem cells (2021 · Journal of Cancer · 被引 30)
• Enforced expression of Runx3 improved CAR-T cell potency in solid tumor via enhancing resistance to activation-induced cell death (2022 · Molecular Therapy · 被引 28)